119 related articles for article (PubMed ID: 38844111)
1. Inhibition of Mettl3 ameliorates osteoblastic senescence by mitigating m6A modifications on Slc1a5 via Igf2bp2-dependent mechanisms.
Liu XW; Xu HW; Yi YY; Zhang SB; Chang SJ; Pan W; Wang SJ
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(7):167273. PubMed ID: 38844111
[TBL] [Abstract][Full Text] [Related]
2. METTL3-mediated m6A modification increases Hspa1a stability to inhibit osteoblast aging.
Wang Y; Chen Y; Xiao H; Liu Z; Liu X; Feng Z; Sheng X; Peng B; Ren X; Xu L; Teng F; Yi Z; Niu Y; Xiang D; Xia Y; Geng B
Cell Death Discov; 2024 Mar; 10(1):155. PubMed ID: 38538596
[TBL] [Abstract][Full Text] [Related]
3. IGF2BP2 Promotes Liver Cancer Growth Through an m6A-FEN1-Dependent Mechanism.
Pu J; Wang J; Qin Z; Wang A; Zhang Y; Wu X; Wu Y; Li W; Xu Z; Lu Y; Tang Q; Wei H
Front Oncol; 2020; 10():578816. PubMed ID: 33224879
[TBL] [Abstract][Full Text] [Related]
4. Genetic and pharmacological inhibition of METTL3 alleviates renal fibrosis by reducing EVL m6A modification through an IGF2BP2-dependent mechanism.
Ni WJ; Zhou H; Lu H; Ma NN; Hou BB; Li W; Kong FX; Yu JT; Hou R; Jin J; Wen JG; Zhang T; Meng XM
Clin Transl Med; 2023 Aug; 13(8):e1359. PubMed ID: 37537731
[TBL] [Abstract][Full Text] [Related]
5. METTL3/IGF2BP2 axis affects the progression of colorectal cancer by regulating m6A modification of STAG3.
Yi J; Peng F; Zhao J; Gong X
Sci Rep; 2023 Oct; 13(1):17292. PubMed ID: 37828232
[TBL] [Abstract][Full Text] [Related]
6. METTL3 counteracts premature aging via m6A-dependent stabilization of MIS12 mRNA.
Wu Z; Shi Y; Lu M; Song M; Yu Z; Wang J; Wang S; Ren J; Yang YG; Liu GH; Zhang W; Ci W; Qu J
Nucleic Acids Res; 2020 Nov; 48(19):11083-11096. PubMed ID: 33035345
[TBL] [Abstract][Full Text] [Related]
7. Chinese Ecliptae herba (Eclipta prostrata (L.) L.) extract and its component wedelolactone enhances osteoblastogenesis of bone marrow mesenchymal stem cells via targeting METTL3-mediated m6A RNA methylation.
Tian S; Li YL; Wang J; Dong RC; Wei J; Ma Y; Liu YQ
J Ethnopharmacol; 2023 Aug; 312():116433. PubMed ID: 37004744
[TBL] [Abstract][Full Text] [Related]
8. METTL3 facilitates prostate cancer progression via inducing HOXC6 m6A modification and stabilizing its expression through IGF2BP2-dependent mechanisms.
He P; Liu X; Yu G; Wang Y; Wang S; Liu J; An Y
Mol Cell Biochem; 2024 May; ():. PubMed ID: 38822192
[TBL] [Abstract][Full Text] [Related]
9. METTL3-mediated m6A modification of SIRT1 mRNA inhibits progression of endometriosis by cellular senescence enhancing.
Wang X; Wang J; Zhao X; Wu H; Li J; Cheng Y; Guo Q; Cao X; Liang T; Sun L; Zhang G
J Transl Med; 2023 Jun; 21(1):407. PubMed ID: 37353804
[TBL] [Abstract][Full Text] [Related]
10. IGF2BP2 promotes pancreatic carcinoma progression by enhancing the stability of B3GNT6 mRNA via m6A methylation.
Cao P; Wu Y; Sun D; Zhang W; Qiu J; Tang Z; Xue X; Qin L
Cancer Med; 2023 Feb; 12(4):4405-4420. PubMed ID: 35908253
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of
Wang JN; Wang F; Ke J; Li Z; Xu CH; Yang Q; Chen X; He XY; He Y; Suo XG; Li C; Yu JT; Jiang L; Ni WJ; Jin J; Liu MM; Shao W; Yang C; Gong Q; Chen HY; Li J; Wu YG; Meng XM
Sci Transl Med; 2022 Apr; 14(640):eabk2709. PubMed ID: 35417191
[TBL] [Abstract][Full Text] [Related]
12. The "m6A writer" METTL3 and the "m6A reader" IGF2BP2 regulate cutaneous T-cell lymphomas progression via CDKN2A.
Wang X; Hu M; Yu L; Wang X; Jiang X; Zhang G; Ding K
Hematol Oncol; 2022 Oct; 40(4):567-576. PubMed ID: 35446451
[TBL] [Abstract][Full Text] [Related]
13. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G
J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207
[TBL] [Abstract][Full Text] [Related]
14. Methyltransferase-like 3 promotes cervical cancer metastasis by enhancing cathepsin L mRNA stability in an N6-methyladenosine-dependent manner.
Liu P; Ju M; Zheng X; Jiang Y; Yu X; Pan B; Luo R; Jia W; Zheng M
Cancer Sci; 2023 Mar; 114(3):837-854. PubMed ID: 36382580
[TBL] [Abstract][Full Text] [Related]
15. Stabilization of UCA1 by N6-methyladenosine RNA methylation modification promotes colorectal cancer progression.
He RZ; Jiang J; Hu X; Lei M; Li J; Luo W; Duan L; Hu Z; Mo YY; Luo DX; Peng WX
Cancer Cell Int; 2021 Nov; 21(1):616. PubMed ID: 34809621
[TBL] [Abstract][Full Text] [Related]
16. METTL3 inhibits BMSC apoptosis and facilitates osteonecrosis repair via an m6A-IGF2BP2-dependent mechanism.
Xie Z; Luo H; Wang T; Wang L; Zhang J; Dong W; Liu G; Li F; Kang Q; Zhu X; Zhang F; Peng W
Heliyon; 2024 May; 10(10):e30195. PubMed ID: 38784565
[TBL] [Abstract][Full Text] [Related]
17. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM
Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881
[TBL] [Abstract][Full Text] [Related]
18. N6-Methyladenosine Modification of PTTG3P Contributes to Colorectal Cancer Proliferation
Zheng Y; Wang Y; Liu Y; Xie L; Ge J; Yu G; Zhao G
Front Oncol; 2021; 11():669731. PubMed ID: 34660259
[TBL] [Abstract][Full Text] [Related]
19. ZBTB7C m6A modification incurred by METTL3 aberration promotes osteosarcoma progression.
An X; Wu W; Yang L; Dong J; Liu B; Guo J; Chen J; Guo B; Cao W; Jiang Q
Transl Res; 2023 Sep; 259():62-71. PubMed ID: 37121538
[TBL] [Abstract][Full Text] [Related]
20. METTL3 promotes nucleus pulposus cell senescence in intervertebral disc degeneration by regulating TLR2 m6A methylation and gut microbiota.
Ni S; Huang X; Li X; Shi C; Fan M; Zhao L; Rong Z; Zhang H
J Gerontol A Biol Sci Med Sci; 2024 Jun; ():. PubMed ID: 38853707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
